VACCINES FOR HEALTHCARE PROVIDERS - ADULT VACCINATION - ADULT IMMUNIZATION - VACCINE FOR ADULTS

For Healthcare Providers
In 1952, close to 60,000 Americans contracted paralytic polio. That number is now zero. And this is not a unique statistic; the morbidity associated with many one-time ubiquitous diseases — smallpox, diphtheria, measles, mumps, rubella — has decreased 99 percent or more for each. These remarkable successes, which provide a definitive answer to any question about the importance of vaccines, are owed to our comprehensive US childhood immunization strategy.

The next imperative is to create a similarly comprehensive strategy for adult immunization to address the fact that the majority of vaccine-preventable deaths in the US today occur in adults. Healthcare providers can and will need to play a pivotal role in these efforts.

This section of Adultvaccination.com provides information about vaccine-preventable diseases and the latest immunization schedule from the Centers for Disease Control and Prevention. In addition, access our professional practice toolkit that contains tools and materials to help your practice improve adult vaccination rates and promote patient education among adults in your care.


Professional Resources

Professional Practice Toolkit: Contains tools and materials to help your practice improve adult vaccination rates and promote patient education among adults in your care.

Pneumococcal Disease Professional Practice Toolkit: Contains tools and materials specific to pneumococcal disease for helping your practice improve adult vaccination rates and promote patient education among adults in your care.

NFID Adult Immunization Resource Center on Medscape: Provides CME activities and other materials focused on adult immunization and adult vaccination.

Downloadable Brief: Understanding the Challenges & Opportunities in Protecting Older Adults from Influenza: The National Foundation for Infectious Diseases convened a panel of experts to help increase understanding of the unique challenges and new opportunities in protecting older Americans from influenza.
 

NFID is pleased to provide a new Joint Commission publication discussing the pressing need to increase pertussis immunization in adolescents and adults. The comprehensive publication [PDF] sets a foundation for health care organizations to enhance Tdap vaccination programs.

 
Contact Us  |  About NFID  |  Call to Action  |  Supporting Organizations This website is supported by unrestricted educational grants from GlaxoSmithKline, Merck & Co., Pfizer Inc., and Sanofi Pasteur. NFID’s policies prohibit funders from controlling program content. This site reflects US immunization policy and is intended for US residents.